Update at 9:25 a.m. — The Food and Drug Administration has warned that it has not authorized at-home testing kits for consumers, according to Bloomberg Law.
Update 5:40 p.m. — Josh Flood, President of CareClix, clarified the earlier information:
Getting access to a provider comes at no cost. The consult is billed through insurance or Medicare. If they’re at home and concerned, talk to a doctor. If they think they have COVID, the kit depends on the testing labs. Getting the testing kit is determined by the doctor and the patient together, they might refer you to a community center. That test is often with no out-of-pocket cost.
Earlier: Alexandria company Solei Systems, Inc. announced this week that one of its subsidiaries is providing screening and testing for COVID-19.
The tests and consultation are free and the company says they can be shipped via U.S. Mail within 24 hours. The results are available on the day that the company, CareClix, Inc., receives the completed test kits.
“Our partnered laboratories can ship COVID-19 testing kits to your residence within 24 hours,” Solei Systems said in a press release. “Patients can provide a small sample and return the sample for next day diagnostic testing. Once the kit has been received by the laboratory and processed, the results will be available within the same day.”
Testing kits are also available in the city at Inova Alexandria Hospital. Local doctors, however, have found difficulty in getting their hands on them. One Alexandria doctor has received hundreds of requests for testing kits, which he has been unable to fulfill, according to WAMU.
The full release is below:
ALEXANDRIA, VA / ACCESSWIRE / March 16, 2020 / Solei Systems, Inc. (OTC PINK:SOLI) announces that its subsidiary, CareClix, Inc., an industry leader in telemedicine, is now providing screening and testing for Coronavirus disease 2019 (COVID-19) to patients in the comfort and safety of their own home.
CareClix has partnered with medical laboratories nationwide including community testing centers. Our partnered laboratories can ship COVID-19 testing kits to your residence within 24 hours. Patients can provide a small sample and return the sample for next day diagnostic testing. Once the kit has been received by the laboratory and processed, the results will be available within the same day.
“Telemedicine was designed for this type of immediate patient care,” states CareClix CEO, Dr. John Korangy. “Our physicians, who follow the CDC recommendations, will perform consultations which include medical, travel history, along with signs and symptoms compatible with COVID-19.”
Dr. Korangy adds, “Telemedicine has grown tremendously. In unfortunate situations like COVID-19, telemedicine has great value. You can access a provider, and see them remotely, through either video consult or telephone consult. Through an observational consultation, the provider can access the patient and help guide them on the best next appropriate steps–this may include staying at home and being managed the way you would with any other infection, or may require an in-person physician, or emergency room visit. Telemedicine allow the potentially infected patient to stay at home which I believe is the ideal way to avoid the risk unnecessary exposure for all concerned–the patients, the care providers, and everyone in the community.”
Our telemedicine solutions help healthcare workers and first responders have the tools to best handle this crisis. CareClix’ physician network can be accessed by PC, mobile platform or phone. CareClix.is urging everyone who is considered high priority, high risk, or symptomatic to begin the testing process by calling 855-CARECLX (855.227.3259) or download the CareClix app from the Apple Store or Google Play and use “covid” as your Clinic ID. Or visit the website www.careclix.com/covid19 and follow the instructions for creating your account. CareClix’s healthcare providers are standing by to connect virtually with the general public to assess their needs and concerns.
About CareClix: CareClix is a leading virtual healthcare solution company that provides software applications coupled with medical services enabling patients to receive care anytime at anyplace. CareClix’s suite of services is revolutionizing the way hospitals, doctors, and clinical care providers can interact with an increasing number of patients. Trusted by some of the best names in healthcare, CareClix has an established track record of success partnering with organizations and customers. More than 10 million individuals in the U.S. in over 60 countries are currently utilizing CareClix’s services. CareClix Inc. is a wholly-owned subsidiary of Solei Systems Inc. (OTC: SOLI). Learn more about CareClix by visiting our website: www.careclix.com.
Solei Systems, Inc. is a fully reporting, fully audited public holding company in the health and wellness field with its primary focus on telemedicine. Currently, Solei Systems, Inc is comprised of two wholly owned subsidiaries: CareClix, Inc. and Clinical & Herbal Innovations, Inc www.soleihealth.com
Cautionary Statement Regarding Forward-Looking Information
This press release may contain certain “forward-looking statements” relating to the business of Solei Systems Inc, and its wholly owned subsidiary CareClix, Inc. All statements, other than statements of historical fact included herein are “forward-looking statements.” These forward-looking statements are often identified using forward-looking terminology such as “believes,” “expects” or similar expressions, involve known and unknown risks and uncertainties. Although Solei Systems, Inc believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Solei Systems, Inc’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Solei’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). All forward-looking statements attributable to Solei Systems or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.